1. Home
  2. AMPH vs TRIN Comparison

AMPH vs TRIN Comparison

Compare AMPH & TRIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • TRIN
  • Stock Information
  • Founded
  • AMPH 1996
  • TRIN 2007
  • Country
  • AMPH United States
  • TRIN United States
  • Employees
  • AMPH N/A
  • TRIN N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • TRIN Finance/Investors Services
  • Sector
  • AMPH Health Care
  • TRIN Finance
  • Exchange
  • AMPH Nasdaq
  • TRIN Nasdaq
  • Market Cap
  • AMPH 1.2B
  • TRIN 1.2B
  • IPO Year
  • AMPH 2014
  • TRIN 2021
  • Fundamental
  • Price
  • AMPH $24.39
  • TRIN $15.06
  • Analyst Decision
  • AMPH Buy
  • TRIN Buy
  • Analyst Count
  • AMPH 6
  • TRIN 4
  • Target Price
  • AMPH $35.50
  • TRIN $15.63
  • AVG Volume (30 Days)
  • AMPH 369.0K
  • TRIN 878.5K
  • Earning Date
  • AMPH 11-06-2025
  • TRIN 11-05-2025
  • Dividend Yield
  • AMPH N/A
  • TRIN 13.67%
  • EPS Growth
  • AMPH N/A
  • TRIN 32.58
  • EPS
  • AMPH 2.68
  • TRIN 2.25
  • Revenue
  • AMPH $722,679,000.00
  • TRIN $254,887,000.00
  • Revenue This Year
  • AMPH $1.00
  • TRIN $27.19
  • Revenue Next Year
  • AMPH $6.74
  • TRIN $8.97
  • P/E Ratio
  • AMPH $9.15
  • TRIN $6.64
  • Revenue Growth
  • AMPH 1.37
  • TRIN 33.44
  • 52 Week Low
  • AMPH $20.39
  • TRIN $12.50
  • 52 Week High
  • AMPH $53.96
  • TRIN $16.82
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 40.87
  • TRIN 47.75
  • Support Level
  • AMPH $22.94
  • TRIN $14.72
  • Resistance Level
  • AMPH $24.87
  • TRIN $15.15
  • Average True Range (ATR)
  • AMPH 0.79
  • TRIN 0.27
  • MACD
  • AMPH 0.12
  • TRIN 0.05
  • Stochastic Oscillator
  • AMPH 42.90
  • TRIN 74.16

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About TRIN Trinity Capital Inc.

Trinity Capital Inc is a closed-end, non-diversified management investment company. The company is engaged in providing debt, including loans and equipment financings, to growth-stage companies, including venture-backed companies and companies with institutional equity investors. Its equipment financings involve loans for general or specific use, including acquiring equipment, secured by the equipment or other assets of the portfolio company.

Share on Social Networks: